GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » MicroTech Medical (Hangzhou) Co Ltd (HKSE:02235) » Definitions » Net Income Including Noncontrolling Interests

MicroTech Medical (Hangzhou) Co (HKSE:02235) Net Income Including Noncontrolling Interests : HK$-157.0 Mil (TTM As of Jun. 2024)


View and export this data going back to 2021. Start your Free Trial

What is MicroTech Medical (Hangzhou) Co Net Income Including Noncontrolling Interests?

Net Income Including Noncontrolling Interests is the net income of the group after the adjustment of all expenses and benefit. It includes the net income (loss) attributable to noncontrolling and redeemable noncontrolling interests and the net income (loss) attributable to the company.

MicroTech Medical (Hangzhou) Co's Net Income Including Noncontrolling Interests for the six months ended in Jun. 2024 was HK$-40.6 Mil. Its Net Income Including Noncontrolling Interests for the trailing twelve months (TTM) ended in Jun. 2024 was HK$-157.0 Mil.

MicroTech Medical (Hangzhou) Co Net Income Including Noncontrolling Interests Historical Data

The historical data trend for MicroTech Medical (Hangzhou) Co's Net Income Including Noncontrolling Interests can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MicroTech Medical (Hangzhou) Co Net Income Including Noncontrolling Interests Chart

MicroTech Medical (Hangzhou) Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Net Income Including Noncontrolling Interests
-87.48 -143.73 -58.96 -39.13 -136.74

MicroTech Medical (Hangzhou) Co Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Net Income Including Noncontrolling Interests Get a 7-Day Free Trial Premium Member Only -9.31 -30.26 -20.41 -116.33 -40.62

MicroTech Medical (Hangzhou) Co Net Income Including Noncontrolling Interests Calculation

Net Income Including Noncontrolling Interests is the net income of the group after the adjustment of all expenses and benefit. It includes the net income (loss) attributable to noncontrolling and redeemable noncontrolling interests and the net income (loss) attributable to the company.

Net Income Including Noncontrolling Interests for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$-157.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MicroTech Medical (Hangzhou) Co Net Income Including Noncontrolling Interests Related Terms

Thank you for viewing the detailed overview of MicroTech Medical (Hangzhou) Co's Net Income Including Noncontrolling Interests provided by GuruFocus.com. Please click on the following links to see related term pages.

MicroTech Medical (Hangzhou) Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » MicroTech Medical (Hangzhou) Co Ltd (HKSE:02235) » Definitions » Net Income Including Noncontrolling Interests
Comparable Companies
HKSE:02160 HKSE:06669 HKSE:09877 HKSE:01696 HKSE:09996 HKSE:02407 HKSE:06922 HKSE:06609 HKSE:02170 HKSE:02216 ABT BSX SYK MDT XTER:SHL EW SZSE:300760 DXCM XAMS:PHIA STE
Traded in Other Exchanges
N/A
Address
No. 108 Liuze Street, Cangqian Street, Yuhang District, Zhejiang Province, Hangzhou, CHN
Website
https://www.microtechmd.com
MicroTech Medical (Hangzhou) Co Ltd is engaged in the research and development and manufacturing and commercialization of diabetes management, providing both diabetes treatment and diabetes monitoring medical devices to improve diabetes management in China and the rest of the world. The company derives a majority of its revenue from China.
Executives
Orbimed Asia Partners V, L.p. 2101 Beneficial owner
Orbimed Asia Gp V, L.p. 2201 Interest of corporation controlled by you
Orbimed Advisors V Limited 2201 Interest of corporation controlled by you
Lilly Asia Ventures Fund Ii, L.p. 2201 Interest of corporation controlled by you
Qm32 Limited 2101 Beneficial owner
Qiming Venture Partners V, L.p. 2201 Interest of corporation controlled by you
Qiming Gp V, L.p. 2201 Interest of corporation controlled by you
Qiming Corporate Gp V, Ltd. 2201 Interest of corporation controlled by you
Lilly Asia Ventures Fund Gp, L.p. 2201 Interest of corporation controlled by you
Lav Evergreen (hong Kong) Co., Limited 2101 Beneficial owner
Lav Corporate Gp, Ltd. 2201 Interest of corporation controlled by you
Zheng Pan
Cd Capital Gp Ltd 2201 Interest of corporation controlled by you
Master Summer Limited 2201 Interest of corporation controlled by you
Cdbi Partners Gp, Ltd 2201 Interest of corporation controlled by you

MicroTech Medical (Hangzhou) Co Headlines

No Headlines